Effect of famotidine on cognitive and behavioral dysfunctions induced in post-COVID-19 infection: A randomized, double-blind, and placebo-controlled study

2023/05/31 by Sara Momtazmanesh, Sahar Ansari, Zahra Izadi +8 · 1 voice
Immunology and Microbiology · Medicine · Neuroscience · #Long-Term Effects of COVID-19 #Mast cells and histamine #Olfactory and Sensory Function Studies

paper · doi:10.1016/j.jpsychores.2023.111389

openalex publication_date 2023/05/31 · crossref created 2023/05/31 · crossref issued 2023/09/01 · crossref published 2023/09/01 · crossref published-print 2023/09/01 · crossref deposited 2024/10/25 · openalex created_date 2025/10/10 · crossref indexed 2026/07/09 · openalex updated_date 2026/07/22

Citations

• The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment
• COVID-19 pandemic and mental health consequences: Systematic review of the current evidence
• Persistent Symptoms in Patients After Acute COVID-19
• Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network — United States, March–June 2020
• Case Report: Famotidine for Neuropsychiatric Symptoms in COVID-19

Discussions

• I haven't figured out how to do links here a lot of the time. I've included the title in case link fails. Effect of famotidine on cognitive and behavioral dysfunctions induced in post-COVID-19 infecti [bsky, 2 points, 1 comments]